.S. FDA Commissioner Hamburg Urges Physicians, Patients to Only Purchase Medicines from Reliable Sources to Better Protect Against Fake Drugs
Washington, D.C. (September 28, 2012) – The Partnership for Safe Medicines (PSM) today convened leading domestic and international stakeholders in the fight against counterfeit and substandard medicines, making a renewed commitment to work together and implement new solutions to protect patients worldwide. U.S. Food and Drug Administration Commissioner Dr. Margaret Hamburg, in a keynote to the conference, highlighted new efforts her agency is undertaking to reduce the threat and pledged the FDA’s ongoing support to ensure a safe U.S. drug supply.
"The American people have every right to expect that the medicines they rely on are exactly what the package and label say they are – and that the medicines have been carefully evaluated by FDA for safety, efficacy, and quality," said FDA Commissioner Margaret A. Hamburg, M.D. "Our success in addressing this global challenge will depend on collaborating with public health and regulatory partners here in the United States and around the world."
PSM Executive Director Scott LaGanga.
Image courtesy of C-SPAN.
Image courtesy of C-SPAN.
“This year’s Interchange was our boldest, most ambitious effort to date,” said PSM President Dr. Marvin D. Shepherd. “By bringing together stakeholders from as far away as India and Great Britain to share information and ideas on how to win the war on counterfeit medicines, we are sending a message to counterfeiters worldwide: the noose is tightening, and you can’t hide forever. As regulators and law enforcement agencies in the U.S. and abroad come to grips with the great public health risk of fake drugs, our efforts and successes will only intensify in the future.” To read more click here
No comments:
Post a Comment